Bioprocess Development Forum - Insights, Solutions, and Shortcuts in Bioprocessing

September 24, 2020

Oligonucleotide Therapeutics Heading for Tons of Quantity in Annual Supply Need

Cytiva

Click here to read the full article >>

Solid-phase flow through technology poised to annually produce metric tons (1000 kg) provides the oligonucleotide therapeutic industry efficient synthesis tools to surge forward.

Tags: Oligonucleotide therapeutics; oligonucleotides; Solid-phase flow through technology; oligo synthesis